Amneal Pharmaceuticals, Inc. AMRX Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Amneal Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s earnings yield?
- Amneal Pharmaceuticals, Inc. (AMRX) reported earnings yield of 3.1% in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s earnings yield changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s earnings yield increased by 719.8% year-over-year, from -0.5% to 3.1%.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s earnings yield?
- Over 4 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s earnings yield has grown at a -39.7% compound annual growth rate (CAGR), from 13.8% to 1.8%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.